Search
for
Sort by
Research 781–810 of 1000+
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Roles of steroid receptors in the lung and COVID-19
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
- The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID‐19
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Caution in the time of rashes and COVID-19
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Meta-analysis of post-traumatic stress disorder and COVID-19 in patients discharged
- Genetic correlation analysis does not associate male pattern baldness with COVID-19
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Androgens’ Role in Severity and Mortality Rates of COVID-19
- New‐onset and exacerbated skin diseases after COVID‐19 infection: A systematic review
- Manifestaciones clínicas y complicaciones de la enfermedad por coronavirus 2019 (COVID-19): revisión de la literatura
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Skin cancer prevention in the Polish population during the COVID-19 pandemic
- A window into the vascular endothelium in COVID-19: Nails
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination